Aripiprazole
Who holds supplier records for Aripiprazole? 43 organisations hold a current record for Aripiprazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 23 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), China (5), Italy (2), Netherlands (2) and 6 other countries (6); not recorded for 5.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Aripiprazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aripiprazole
Reading the evidence
- 43 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
23 of the 38 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 25 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Aripiprazole expires 15 Dec 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (43)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Aripiprazole. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 23300, 43624 · latest filing Mar 2026
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 33827, 24997 · latest filing Apr 2019
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 22563, 31455 · latest filing Mar 2017
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 31257, 19554 · latest filing Dec 2016
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 24090, 29135 · latest filing Mar 2015
- Neuland Laboratories LimitedIndiaCEPActive DMF 22889, 36451 · latest filing Nov 2021
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 23314, 33204 · latest filing Oct 2018
- INTERQUIM SAPeru Company GMP cert on recordActive DMF 37184, 34969 · latest filing Aug 2022
- Alkem Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 27909 · latest filing Feb 2014
- Cadila Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 20464, 29680 · latest filing Sept 2015
- COHANCE LIFESCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 22825, 30120 · latest filing Dec 2015
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 19739 · latest filing Aug 2006
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 25472 · latest filing Jan 2012
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 19920 · latest filing Nov 2006
- RUYUAN HEC PHARM CO LTDCEPActive DMF 30954 · latest filing Sept 2016
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 22339, 29991 · latest filing Nov 2015
- TAPI NL BVNetherlandsCEPActive DMF 19926 · latest filing Nov 2006
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 24098 · latest filing Sept 2010
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 25685 · latest filing Dec 2011
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 19841 · latest filing Oct 2006
- Apotex Inc.CanadaActive DMF 19957 · latest filing Nov 2006
- CAMBREX CHARLES CITY INCUnited StatesActive DMF 18774 · latest filing Sept 2005
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaActive DMF 40738 · latest filing Feb 2025
- ERREGIERRE SPAItaly Company GMP cert on recordActive DMF 18706 · latest filing Aug 2005
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 36260 · latest filing Sept 2021
- INDOCO REMEDIES LTDIndia Company GMP cert on recordActive DMF 33962 · latest filing Jul 2019
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 21937 · latest filing Sept 2008
- QILU PHARMACEUTICAL CO LTD (LAOLING SITE)Active DMF 40336 · latest filing Aug 2024
- Qilu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 40214 · latest filing Aug 2024
- REYOUNG CORPORATIONActive DMF 36723 · latest filing Feb 2022
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 19949, 36774 · latest filing Feb 2022
- SURAJ LABORATORIES PRIVATE LIMITEDIndiaActive DMF 41458 · latest filing Mar 2025
- TAI HENG INDUSTRY CO LTDActive DMF 19982 · latest filing Oct 2006
- TOPHARMAN SHANDONG CO LTDChinaActive DMF 28563 · latest filing Sept 2014
- ULKAR KIMYA SANAYII VE TICARET ASActive DMF 24937 · latest filing May 2011
- VASUDHA PHARMA CHEM LTDIndiaActive DMF 43774 · latest filing Mar 2026
- WOCKHARDT BIO AGSwitzerlandActive DMF 26743 · latest filing Feb 2013
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 43802 · latest filing Mar 2026
- ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDChina Company GMP cert on recordActive DMF 25996, 32447 · latest filing Jul 2018
- IndiaCEP Company GMP cert on record
- HungaryCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- SynthonNetherlandsCEP Company GMP cert on recordInactive DMF 19682 · latest filing Aug 2006
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (23)
Certificates of Suitability on the EDQM register for Aripiprazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 34 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy | IN | CEP 2014-285 - Rev 02 Aripiprazole, Type-1, Micronised and Non-micronised | Oct 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2020-311 - Rev 03 Aripiprazole, Process IV | Oct 2026 | — |
| BAL PHARMA LIMITED Bengaluru | IN | CEP 2023-383 - Rev 01 Aripiprazole | Oct 2026 | — |
| SYNTHON B.V. Nijmegen | NL | CEP 2019-191 - Rev 03 Aripiprazole, Micronised | Oct 2026 | Inspected May 2024 Netherlands |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2021-282 - Rev 01 Aripiprazole, 1280 | Aug 2026 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2015-010 - Rev 03 Aripiprazole | Jul 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2014-011 - Rev 02 Aripiprazole, Form-B, micronised and non-micronised | Jun 2026 | Inspected May 2026 Italy |
| ALKEM LABORATORIES LIMITED Mumbai | IN | CEP 2024-180 - Rev 00 Aripiprazole | Jan 2026 | — |
| NEULAND LABORATORIES LIMITED Hyderabad | IN | CEP 2017-289 - Rev 04 Aripiprazole, Form B | Jan 2026 | — |
| OLON S.P.A. Rodano | IT | CEP 2014-188 - Rev 02 Aripiprazole | Dec 2025 | Inspected Mar 2025 Italy |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2013-324 - Rev 02 Aripiprazole | Nov 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2013-330 - Rev 03 Aripiprazole | Sept 2025 | — |
| NIFTY LABS PRIVATE LIMITED Hyderabad | IN | CEP 2017-198 - Rev 04 Aripiprazole | Sept 2025 | — |
| ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański | PL | CEP 2013-230 - Rev 03 Aripiprazole | Sept 2025 | Inspected Jul 2026 Poland |
| TAPI NL B.V. Amsterdam | NL | CEP 2018-267 - Rev 03 Aripiprazole, Form II | Jun 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2013-361 - Rev 02 Aripiprazole, Type-I | May 2025 | — |
| CADILA PHARMACEUTICALS LIMITED Ankleshwar | IN | CEP 2016-308 - Rev 02 Aripiprazole, Form 1 | Dec 2024 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2013-292 - Rev 02 Aripiprazole | Aug 2024 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2022-435 - Rev 00 Aripiprazole | Aug 2024 | — |
| COHANCE LIFESCIENCES LIMITED Mumbai | IN | CEP 2016-021 - Rev 02 Aripiprazole | Jul 2024 | — |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | R1-CEP 2016-208 - Rev 00 Aripiprazole | Jun 2023 | — |
| EGIS Pharmaceuticals PLC Budapest | HU | R1-CEP 2014-252 - Rev 02 Aripiprazole | Jul 2022 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R0-CEP 2019-002 - Rev 01 Aripiprazole | Jul 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Aripiprazole are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- India · Inactive DMF 29138 · filed Mar 2015
- China · Inactive DMF 28341 · filed Jun 2014
- Argentina · Inactive DMF 26921 · filed Feb 2013
- India · Inactive DMF 20189 · filed Jul 2007
- India · Inactive DMF 19203 · filed Feb 2006
- India · Inactive DMF 18471 · filed Jun 2005
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (115 listed products contain Aripiprazole). The latest listed patent expires 15 Dec 2041. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Aripiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and bipolar disorder. It is notable for its unique mechanism of action that involves partial agonist activity at D2 dopamine and 5-HT1A serotonin receptors.
Chemical identity
- IUPAC name
- 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
- Canonical SMILES
- C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
- InChIKey
- CEUORZQYGODEFX-UHFFFAOYSA-N
- Synonyms
- Abilify API, abilify, abilify maintena, abilify mycite, abilify mycite kit, aripiprex, mezofy, nsc-759266, opc-14597, opc-31
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Atypical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Aripiprazole?
43 organisations hold an active US FDA Type II Drug Master File or a CEP for Aripiprazole: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Hetero Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), Neuland Laboratories Limited (India), Zakłady Farmaceutyczne Polpharma S.A. (Poland) and INTERQUIM SA (Peru), and 35 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Aripiprazole Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 23300, 43624), APITORIA PHARMA PRIVATE LTD (DMF 33827, 24997), Hetero Labs Limited (DMF 22563, 31455), MATRIX PHARMACORP PRIVATE LTD (DMF 31257, 19554), MSN PHARMACHEM PRIVATE LTD (DMF 24090, 29135), Neuland Laboratories Limited (DMF 22889, 36451), Zakłady Farmaceutyczne Polpharma S.A. (DMF 23314, 33204) and INTERQUIM SA (DMF 37184, 34969) and 31 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Aripiprazole records mean?
6 organisations have only inactive Type II DMFs for Aripiprazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Aripiprazole have a European Certificate of Suitability?
Yes. 23 organisations hold a valid CEP for Aripiprazole on the EDQM register, including MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), BAL PHARMA LIMITED Bengaluru (IN), SYNTHON B.V. Nijmegen (NL), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and UNICHEM LABORATORIES LIMITED Mumbai (IN) and 17 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Aripiprazole?
Yes. The latest patent listed for an approved US product containing Aripiprazole expires 15 Dec 2041, across 115 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Aripiprazole supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Aripiprazole?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.